Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 1.66B 246M 213M 200M 183M 345M 23.42B 350M 2.34B 917M 11.7B 923M 903M 38.95B P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 1.74B 258M 224M 209M 191M 361M 24.54B 366M 2.45B 961M 12.26B 967M 946M 40.8B EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
52.84%
Yield 2024 *
-
Yield 2025 -
05-08 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
04-29 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-29 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-12 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
11-07 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
30/10/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
14/10/25 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
15/09/25 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
27/08/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
10/02/25 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
26/12/24 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day+3.16%
1 week+5.88%
Current month+5.45%
1 month+3.78%
3 months-3.69%
6 months+5.24%
Current year+7.41%
1 week 4.88
Extreme 4.88
5.24
1 month 4.5
Extreme 4.5
5.24
Current year 4.32
Extreme 4.32
5.65
1 year 4.32
Extreme 4.32
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 06/12/2018
Director of Finance/CFO 52 23/12/2013
Corporate Officer/Principal 54 11/12/2020
Director TitleAgeSince
Chairman 33 06/12/2018
Director/Board Member 54 11/12/2020
Director/Board Member 66 11/12/2020
Date Insider Type Main position Quantity % Market Cap.
25/7/23 Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
+3.16%+5.88%+9.21%-0.38% 238M
+0.74%+1.92%+57.71%+159.23% 1,043B
-0.47%+0.29%+50.40%+48.22% 621B
-1.32%-5.55%+23.86%+61.73% 435B
0.00%+3.20%+46.70%+37.70% 361B
+0.58%-1.26%+35.52%+39.32% 293B
-1.55%-6.84%+7.20%+8.86% 251B
-1.39%+3.66%+41.16%+58.87% 220B
-0.24%-11.27%+1.42%-46.20% 201B
-1.90%-1.20%+17.61%+60.78% 164B
Average -0.17%-2.88%+29.08%+42.81% 358.94B
Weighted average by Cap. -0.21%-3.79%+39.89%+73.51%

Financials

2024 2025
Net sales 570M 84.39M 73.23M 68.57M 62.73M 118M 8.04B 120M 802M 315M 4.02B 317M 310M 13.37B 514M 76.15M 66.08M 61.88M 56.6M 107M 7.25B 108M 724M 284M 3.62B 286M 280M 12.06B
Net income -87.4M -12.95M -11.23M -10.52M -9.62M -18.17M -1.23B -18.4M -123M -48.3M -616M -48.61M -47.55M -2.05B -55.42M -8.21M -7.12M -6.67M -6.1M -11.52M -782M -11.67M -78.04M -30.63M -391M -30.82M -30.15M -1.3B
Net Debt 97.19M 14.4M 12.49M 11.7M 10.7M 20.2M 1.37B 20.46M 137M 53.71M 685M 54.05M 52.87M 2.28B 78.93M 11.69M 10.15M 9.5M 8.69M 16.41M 1.11B 16.62M 111M 43.62M 556M 43.89M 42.94M 1.85B
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
06/08/26 CN¥5.220 +3.16% 3,045,200
05/08/26 CN¥5.060 +0.20% 2,047,400
04/08/26 CN¥5.050 0.00% 2,688,100
03/08/26 CN¥5.050 +2.02% 1,594,750
31/07/26 CN¥4.950 +1.23% 1,487,950
  1. Stock Market
  2. Stocks
  3. 002872 Stock